A shroud for a mask system includes a retaining portion structured to retain a frame, a pair of upper headgear connectors each including an elongated arm and a slot at the free end of the arm adapted to receive a headgear strap, and a pair of lower headgear connectors each adapted to attach to a headgear strap. The retaining portion, the upper headgear connectors, and the lower headgear connectors are integrally formed as a one piece structure.

A wye connector has a patient coupling end. The patient coupling end has a first connector surface and a second connector surface. The first connector surface has a first diameter at an axial location along the patient coupling end. The second connector surface has a second diameter at the same axial location along the patient coupling end. The first diameter is larger than the second diameter. The second connector surface projects axially outward beyond the first connector surface.

A shroud for a mask system includes a retaining portion structured to retain a frame, a pair of upper headgear connectors each including an elongated arm and a slot at the free end of the arm adapted to receive a headgear strap, and a pair of lower headgear connectors each adapted to attach to a headgear strap. The retaining portion, the upper headgear connectors, and the lower headgear connectors are integrally formed as a one piece structure.

A breathing assistance device with improved pressure characteristics provides a high level of CPAP per unit of supplementary respirable gas consumed while maintaining low CPAP fluctuations throughout the breath cycle utilizing a frustrum-shaped air channel to accelerate air flow. In some embodiments, a manometer is provided for monitoring pressure and/or a pressure relief valve is provided as a safety measure against overpressure delivered to a patient. In some embodiments, the device is disposable for one-time or single patient use.

The present invention relates to a tracheal coupling comprising a patient port 33, an outlet port 36, an inlet port 31 between the patient port and the outlet port, such that flow 34 from the inlet port can go to the patient port or direct to the outlet port, and a flow restriction e.g. 32 between the inlet port and the outlet port, or at the outlet port.

A supplemental gas delivery device is described for a mask assembly having at least one supplemental gas port, the at least one supplemental gas port including an aperture in communication with an interior of the mask assembly. The mask assembly may include an aperture communicating with an interior of the mask assembly, and a cannula for communicating with the supplemental gas port. The cannula is positioned to deliver supplemental gas adjacent to the patient's nares and/or mouth, to increase an efficacy of treatment for the patient by more directly applying the flow of supplemental gas to the patient's nares. An optional bridging portion may be included to provide a connection between supplemental gas port and the cannula.

A high flow therapy system for delivering heated and humidified respiratory gas to an airway of a patient, the system including a respiratory gas flow pathway for delivering the respiratory gas to the airway of the patient by way of a non-sealing respiratory interface; wherein flow rate of the pressurized respiratory gas is controlled by a microprocessor.

A medical device measures a pressure of a pressurized breathing gas and includes a pressure sensor arranged at a point of measurement and measures the pressure of a sample gas at a sampling point. The sampling point and the point of measurement are connected by a pressure sampling tube in which a pressure wave of the sample gas can propagate from the sampling point to the point of measurement. The tube has a sampling tube volume and an acoustic impedance. The device further includes a damping arrangement fluidly communicating with the tube. The damping arrangement includes a flow restrictor and a receptor chamber arrangement. The receptor arrangement includes a receptor chamber which receives the pressure wave. The restrictor correlates to the acoustic impedance to prevent acoustic resonance in the tube. The receptor chamber correlates at least to the tube volume to prevent acoustic resonance in the tube.

A method of assessing airway clearance therapy efficacy includes generating a pressure pulse in a respiratory device being used by a patient. The patient's lung impedance is measured during the pressure pulse and the patient's lung condition is assessed based on the patient's lung impedance. The patient's lung condition is then assessed after airway clearance therapy.

A medical monitoring system for identifying an end-exhalation carbon dioxide value of enhanced clinical utility is described herein. The medical monitoring system can include a capnometer for generating an output corresponding to a time-series of exhaled carbon dioxide values from a patient during an exhalation and a processor programmed to analyze the exhalation. In some examples, the processor can also be programmed to identify a peak carbon dioxide value at an end of the exhalation, determine if the peak carbon dioxide value may have been higher if the exhalation had been prolonged, and provide an output responsive to said determination.